USFDA completes inspection at Andhra Pradesh facility of Aurobindo Pharma’s arm

19 Feb 2025 Evaluate

The United States Food and Drug Administration (USFDA) has concluded the Pre-Approval Inspection (PAI) at Andhra Pradesh facility of Eugia Steriles, a stepdown subsidiary of Aurobindo Pharma. The inspection conducted from February 10, 2025 to February 18, 2025.

The inspection concluded with 5 observations. The observations are procedural in nature and will be responded to within the stipulated time.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1172.30 -7.95 (-0.67%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×